METHOD FOR PREDICTING UNFAVORABLE CLINICAL COURSE OF UVEITIS

METHOD FOR PREDICTING UNFAVORABLE CLINICAL COURSE OF UVEITIS

FIELD: medicine. ^ SUBSTANCE: method involves introducing inactivated herpes simplex virus into mixed peripheral blood leukocyte culture taken from uveitis patient at the beginning of culturing. Tumor necrosis factor - alpha (TNF-alpha) and interleukin 4 (IL-4) content is determined 24 hours later f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BYKOVSKAJA GALINA NIKOLAEVNA, DENISOVA EKATERINA VALER'EVNA, VELICHKO TAT'JANA VLADIMIROVNA, KATARGINA LJUDMILA ANATOL'EVNA, SLEPOVA OL'GA SEMENOVNA
Format: Patent
Sprache:eng ; rus
Schlagworte:
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator BYKOVSKAJA GALINA NIKOLAEVNA
DENISOVA EKATERINA VALER'EVNA
VELICHKO TAT'JANA VLADIMIROVNA
KATARGINA LJUDMILA ANATOL'EVNA
SLEPOVA OL'GA SEMENOVNA
description FIELD: medicine. ^ SUBSTANCE: method involves introducing inactivated herpes simplex virus into mixed peripheral blood leukocyte culture taken from uveitis patient at the beginning of culturing. Tumor necrosis factor - alpha (TNF-alpha) and interleukin 4 (IL-4) content is determined 24 hours later from the beginning of culturing in supernatant. TNF-alpha content being greater than 200 pkg/ml without IL-4 being found, unfavorable clinical course of uveitis is to be predicted. ^ EFFECT: high accuracy in forecasting disease relapse cases at preclinical stage; enhanced effectiveness of treatment.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2298188C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2298188C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2298188C13</originalsourceid><addsrcrecordid>eNrjZLDxdQ3x8HdRcPMPUggIcnXxdA7x9HNXCPVzcwzzD3J08nFVcPbx9PN0dvRRcPYPDQp2VfB3UwgNc_UM8QzmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxQaFGRpYWhhYWzobGRCgBAMAYKXM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD FOR PREDICTING UNFAVORABLE CLINICAL COURSE OF UVEITIS</title><source>esp@cenet</source><creator>BYKOVSKAJA GALINA NIKOLAEVNA ; DENISOVA EKATERINA VALER'EVNA ; VELICHKO TAT'JANA VLADIMIROVNA ; KATARGINA LJUDMILA ANATOL'EVNA ; SLEPOVA OL'GA SEMENOVNA</creator><creatorcontrib>BYKOVSKAJA GALINA NIKOLAEVNA ; DENISOVA EKATERINA VALER'EVNA ; VELICHKO TAT'JANA VLADIMIROVNA ; KATARGINA LJUDMILA ANATOL'EVNA ; SLEPOVA OL'GA SEMENOVNA</creatorcontrib><description>FIELD: medicine. ^ SUBSTANCE: method involves introducing inactivated herpes simplex virus into mixed peripheral blood leukocyte culture taken from uveitis patient at the beginning of culturing. Tumor necrosis factor - alpha (TNF-alpha) and interleukin 4 (IL-4) content is determined 24 hours later from the beginning of culturing in supernatant. TNF-alpha content being greater than 200 pkg/ml without IL-4 being found, unfavorable clinical course of uveitis is to be predicted. ^ EFFECT: high accuracy in forecasting disease relapse cases at preclinical stage; enhanced effectiveness of treatment.</description><language>eng ; rus</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20070427&amp;DB=EPODOC&amp;CC=RU&amp;NR=2298188C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20070427&amp;DB=EPODOC&amp;CC=RU&amp;NR=2298188C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BYKOVSKAJA GALINA NIKOLAEVNA</creatorcontrib><creatorcontrib>DENISOVA EKATERINA VALER'EVNA</creatorcontrib><creatorcontrib>VELICHKO TAT'JANA VLADIMIROVNA</creatorcontrib><creatorcontrib>KATARGINA LJUDMILA ANATOL'EVNA</creatorcontrib><creatorcontrib>SLEPOVA OL'GA SEMENOVNA</creatorcontrib><title>METHOD FOR PREDICTING UNFAVORABLE CLINICAL COURSE OF UVEITIS</title><description>FIELD: medicine. ^ SUBSTANCE: method involves introducing inactivated herpes simplex virus into mixed peripheral blood leukocyte culture taken from uveitis patient at the beginning of culturing. Tumor necrosis factor - alpha (TNF-alpha) and interleukin 4 (IL-4) content is determined 24 hours later from the beginning of culturing in supernatant. TNF-alpha content being greater than 200 pkg/ml without IL-4 being found, unfavorable clinical course of uveitis is to be predicted. ^ EFFECT: high accuracy in forecasting disease relapse cases at preclinical stage; enhanced effectiveness of treatment.</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDxdQ3x8HdRcPMPUggIcnXxdA7x9HNXCPVzcwzzD3J08nFVcPbx9PN0dvRRcPYPDQp2VfB3UwgNc_UM8QzmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxQaFGRpYWhhYWzobGRCgBAMAYKXM</recordid><startdate>20070427</startdate><enddate>20070427</enddate><creator>BYKOVSKAJA GALINA NIKOLAEVNA</creator><creator>DENISOVA EKATERINA VALER'EVNA</creator><creator>VELICHKO TAT'JANA VLADIMIROVNA</creator><creator>KATARGINA LJUDMILA ANATOL'EVNA</creator><creator>SLEPOVA OL'GA SEMENOVNA</creator><scope>EVB</scope></search><sort><creationdate>20070427</creationdate><title>METHOD FOR PREDICTING UNFAVORABLE CLINICAL COURSE OF UVEITIS</title><author>BYKOVSKAJA GALINA NIKOLAEVNA ; DENISOVA EKATERINA VALER'EVNA ; VELICHKO TAT'JANA VLADIMIROVNA ; KATARGINA LJUDMILA ANATOL'EVNA ; SLEPOVA OL'GA SEMENOVNA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2298188C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2007</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>BYKOVSKAJA GALINA NIKOLAEVNA</creatorcontrib><creatorcontrib>DENISOVA EKATERINA VALER'EVNA</creatorcontrib><creatorcontrib>VELICHKO TAT'JANA VLADIMIROVNA</creatorcontrib><creatorcontrib>KATARGINA LJUDMILA ANATOL'EVNA</creatorcontrib><creatorcontrib>SLEPOVA OL'GA SEMENOVNA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BYKOVSKAJA GALINA NIKOLAEVNA</au><au>DENISOVA EKATERINA VALER'EVNA</au><au>VELICHKO TAT'JANA VLADIMIROVNA</au><au>KATARGINA LJUDMILA ANATOL'EVNA</au><au>SLEPOVA OL'GA SEMENOVNA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD FOR PREDICTING UNFAVORABLE CLINICAL COURSE OF UVEITIS</title><date>2007-04-27</date><risdate>2007</risdate><abstract>FIELD: medicine. ^ SUBSTANCE: method involves introducing inactivated herpes simplex virus into mixed peripheral blood leukocyte culture taken from uveitis patient at the beginning of culturing. Tumor necrosis factor - alpha (TNF-alpha) and interleukin 4 (IL-4) content is determined 24 hours later from the beginning of culturing in supernatant. TNF-alpha content being greater than 200 pkg/ml without IL-4 being found, unfavorable clinical course of uveitis is to be predicted. ^ EFFECT: high accuracy in forecasting disease relapse cases at preclinical stage; enhanced effectiveness of treatment.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; rus
recordid cdi_epo_espacenet_RU2298188C1
source esp@cenet
subjects INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
title METHOD FOR PREDICTING UNFAVORABLE CLINICAL COURSE OF UVEITIS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T17%3A54%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BYKOVSKAJA%20GALINA%20NIKOLAEVNA&rft.date=2007-04-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2298188C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true